{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T02:22:35Z","timestamp":1778552555107,"version":"3.51.4"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["R01-DA021525"],"award-info":[{"award-number":["R01-DA021525"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","ijdp.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.drugpo.2017.02.009","type":"journal-article","created":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T23:01:54Z","timestamp":1490050914000},"page":"63-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["High-intensity cannabis use and HIV clinical outcomes among HIV-positive people who use illicit drugs in Vancouver, Canada"],"prefix":"10.1016","volume":"42","author":[{"given":"Stephanie","family":"Lake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rielle","family":"Capler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannie","family":"Shoveller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Montaner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-J.","family":"Milloy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugpo.2017.02.009_bib0005","doi-asserted-by":"publisher","first-page":"258","DOI":"10.7326\/0003-4819-139-4-200308190-00008","article-title":"Short-term effects of cannabinoids in patients with HIV-1 infection: A randomized, placebo-controlled clinical trial","volume":"139","author":"Abrams","year":"2003","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0010","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12879-015-0913-0","article-title":"Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: A longitudinal analysis","volume":"15","author":"Azar","year":"2015","journal-title":"BMC Infectious Diseases"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0015","series-title":"Cannabis as therapy for people living with HIV\/AIDS","author":"Belle-Isle","year":"2006"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0020","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10865-012-9458-5","article-title":"Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms","volume":"37","author":"Bonn-Miller","year":"2014","journal-title":"Journal of Behavioral Medicine"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0025","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/00002030-200103090-00016","article-title":"Mary-Jane and her patients: Sociodemographic and clinical characteristics of HIV-positive individuals using medical marijuana and antiretroviral agents","volume":"15","author":"Braitstein","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0030","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1111\/j.1360-0443.2010.02911.x","article-title":"Impairment due to cannabis and ethanol: Clinical signs and additive effects","volume":"105","author":"Bramness","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0035","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/S0140-6736(00)02854-3","article-title":"Adverse effects of antiretroviral therapy","volume":"356","author":"Carr","year":"2000","journal-title":"The Lancet"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0040","doi-asserted-by":"publisher","first-page":"S318","DOI":"10.1086\/522557","article-title":"Optimizing treatment outcomes in HIV-infected patients with substance abuse issues","volume":"45","author":"Celentano","year":"2007","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0045","series-title":"Regulation of retail dealers - medical marijuana-related uses [Vancouver]","author":"City of Vancouver","year":"2015"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0050","series-title":"Regulations for medical marijuana-related businesses","author":"City of Vancouver","year":"2016"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0055","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy","volume":"365","author":"Cohen","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0060","series-title":"Deux Canadiens sur trois pr\u00eats \u00e0 l\u00e9galiser la marijuana [Two-thirds of Canadians support legalizing marijuana]","author":"de Grandpr\u00e9","year":"2015"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0065","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200501010-00008","article-title":"Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea","volume":"38","author":"de Jong","year":"2005","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0070","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.forsciint.2014.12.018","article-title":"The combined effects of alcohol and cannabis on driving: Impact on crash risk","volume":"248","author":"Dubois","year":"2015","journal-title":"Forensic Science International"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0075","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/09540120600841930","article-title":"Marijuana as therapy for people living with HIV\/AIDS: Social and health aspects","volume":"19","author":"Fogarty","year":"2007","journal-title":"AIDS Care"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0080","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1089\/108729104323038892","article-title":"Medicinal and recreational marijuana use by patients infected with HIV","volume":"18","author":"Furler","year":"2004","journal-title":"AIDS Patient Care and STDs"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0085","first-page":"690","article-title":"Recreational drug use among individuals living with HIV in Europe: Review of the prevalence, comparison with the general population and HIV guidelines recommendations","volume":"6","author":"Garin","year":"2015","journal-title":"Frontiers in Microbiology"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0090","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1093\/cid\/ciu187","article-title":"HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens","volume":"58","author":"Ghosn","year":"2014","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0095","series-title":"A majority favors marijuana legalization for first time, according to nation\u2019s most authoritative survey [Washington Post]","author":"Ingraham","year":"2015"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0100","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1007\/s10461-013-0619-5","article-title":"Opioid analgesic misuse is associated with incomplete antiretroviral adherence in a cohort of HIV-infected indigent adults in San Francisco","volume":"18","author":"Jeevanjee","year":"2014","journal-title":"AIDS and Behavior"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0105","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/MCP.0000000000000026","article-title":"Marijuana and lung diseases","volume":"20","author":"Joshi","year":"2014","journal-title":"Current Opinion in Pulmonary Medicine"},{"issue":"Suppl 1","key":"10.1016\/j.drugpo.2017.02.009_bib0110","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1093\/infdis\/jis927","article-title":"An epidemiologic update on hepatitis C infection in persons living with or at risk of HIV infection","volume":"207","author":"Kim","year":"2013","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0115","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.drugalcdep.2015.05.014","article-title":"Is cannabis use associated with less opioid use among people who inject drugs?","volume":"153","author":"Kral","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0120","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/dar.12275","article-title":"A safer alternative: Cannabis substitution as harm reduction","volume":"34","author":"Lau","year":"2015","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0125","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.addbeh.2006.03.030","article-title":"The use of GEE for analyzing longitudinal binomial data: A primer using data from a tobacco intervention","volume":"32","author":"Lee","year":"2007","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0130","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200107010-00006","article-title":"Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection","volume":"27","author":"Lucas","year":"2001","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0135","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200203290-00012","article-title":"Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic","volume":"16","author":"Lucas","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0140","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3109\/16066359.2012.733465","article-title":"Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients","volume":"21","author":"Lucas","year":"2013","journal-title":"Addiction Research and Theory"},{"issue":"3","key":"10.1016\/j.drugpo.2017.02.009_bib0145","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/dar.12323","article-title":"Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors","volume":"35","author":"Lucas","year":"2015","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0150","article-title":"No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort)","author":"Marcellin","year":"2016","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0155","unstructured":"Marihuana for Medical Purposes Regulations, SOR\/2013-119. (2012). Canada Gazette, Part II: 146(50). Retrieved from http:\/\/gazette.gc.ca\/rp-pr\/p1\/2012\/2012-12-15\/html\/reg4-eng.html."},{"key":"10.1016\/j.drugpo.2017.02.009_bib0160","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.drugalcdep.2007.02.024","article-title":"Concurrent and simultaneous drug and alcohol use: Results of the 2000 National Alcohol Survey","volume":"90","author":"Midanik","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0165","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1089\/apc.2011.0169","article-title":"Homelessness as a structural barrier to effective antiretroviral therapy among HIV-seropositive illicit drug users in a Canadian setting","volume":"26","author":"Milloy","year":"2012","journal-title":"AIDS Patient Care and STDs"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0170","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/dar.12223","article-title":"High-intensity cannabis use associated with lower plasma human immunodeficiency virus-1 RNA viral load among recently infected people who use injection drugs","volume":"34","author":"Milloy","year":"2015","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0175","article-title":"Increased prevalence of controlled viremia and decreased rates of HIV drug resistance among HIV-positive people who use illicit drugs during a community-wide Treatment-as-Prevention initiative","author":"Milloy","year":"2015","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0180","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1089\/aid.2010.0218","article-title":"Cannabinoid administration attenuates the progression of simian immunodeficiency virus","volume":"27","author":"Molina","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0185","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/S0140-6736(10)60936-1","article-title":"Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: A population-based study","volume":"376","author":"Montaner","year":"2010","journal-title":"The Lancet"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0190","doi-asserted-by":"publisher","first-page":"e87872","DOI":"10.1371\/journal.pone.0087872","article-title":"Expansion of HAART coverage is associated with sustained decreases in HIV\/AIDS morbidity, mortality and HIV transmission: The \u201cHIV Treatment as Prevention\u201d experience in a Canadian setting","volume":"9","author":"Montaner","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0195","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1525-1497.2004.40081.x","article-title":"Respiratory effects of marijuana and tobacco use in a U.S. sample","volume":"20","author":"Moore","year":"2005","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0200","series-title":"State Medical Marijuana Laws","author":"National Conference of State Legislatures","year":"2016"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0205","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1080\/09540121.2010.543882","article-title":"Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting","volume":"23","author":"Nolan","year":"2011","journal-title":"AIDS Care"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0210","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1097\/QAD.0000000000000642","article-title":"The causal effect of opioid substitution treatment on HAART medication refill adherence","volume":"29","author":"Nosyk","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0215","unstructured":"Minister of Justice and Attorney General of Canada Mandate Letter, 2015. Government of Canada. Retrieved from http:\/\/pm.gc.ca\/eng\/minister-justice-and-attorney-general-canada-mandate-letter."},{"key":"10.1016\/j.drugpo.2017.02.009_bib0220","article-title":"Marijuana use and viral suppression in persons receiving medical care for HIV-infection","volume":"1\u20138","author":"Okafor","year":"2016","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0225","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/00126334-200304150-00009","article-title":"Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use","volume":"32","author":"Palepu","year":"2003","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0230","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/00126334-200401010-00005","article-title":"Patterns of marijuana use among patients with HIV\/AIDS followed in a public health care setting","volume":"35","author":"Prentiss","year":"2004","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0235","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1097\/QAD.0000000000000853","article-title":"Socioeconomic marginalization and plasma HIV-1 RNA nondetectability among individuals who use illicit drugs in a Canadian setting","volume":"29","author":"Richardson","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0240","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s10461-011-0124-7","article-title":"Association between use of specific drugs and antiretroviral adherence: Findings from MACH 14","volume":"17","author":"Rosen","year":"2013","journal-title":"AIDS and Behavior"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0245","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1177\/1545109705284353","article-title":"Nonadherence to antiretroviral therapy among a community with endemic rates of injection drug use","volume":"4","author":"Shannon","year":"2005","journal-title":"Journal of the International Association of Physicians in AIDS Care"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0250","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1093\/ntr\/ntt099","article-title":"Cigarette smoking and quit attempts among injection drug users in Tijuana, Mexico","volume":"15","author":"Shin","year":"2013","journal-title":"Nicotine and Tobacco Research"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0255","first-page":"1","article-title":"High-intensity cannabis use and adherence to antiretroviral therapy among people who use illicit drugs in a Canadian setting","author":"Slawson","year":"2014","journal-title":"AIDS and Behavior"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0260","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1080\/09540120802511869","article-title":"The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: A qualitative study","volume":"21","author":"Small","year":"2009","journal-title":"AIDS Care"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0265","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1080\/09540121.2015.1124983","article-title":"Combined effects of HIV and marijuana use on neurocognitive functioning and immune status","volume":"28","author":"Thames","year":"2016","journal-title":"AIDS Care"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0270","series-title":"Police release a new policy for drug crimes [Canada.com]","author":"The Vancouver Province","year":"2006"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0275","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0002-9343(03)00093-7","article-title":"Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection","volume":"114","author":"Tucker","year":"2003","journal-title":"The American Journal of Medicine"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0280","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1097\/00002030-200304110-00014","article-title":"Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic","volume":"17","author":"Tyndall","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0285","series-title":"90-90-90: An ambitious treatment target to help end the AIDS epidemic [Geneva]","author":"UNAIDS","year":"2014"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0290","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.drugalcdep.2013.03.024","article-title":"Patterns of injection drug use cessation during an expansion of syringe exchange services in a Canadian setting","volume":"132","author":"Werb","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0295","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/cid\/cir491","article-title":"Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy","volume":"53","author":"Westergaard","year":"2011","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0300","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1071\/SH04020","article-title":"Predictors for non-adherence to antiretroviral therapy","volume":"1","author":"Wilson","year":"2004","journal-title":"Sexual Health"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0305","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b1649","article-title":"Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: Prospective cohort study","volume":"338","author":"Wood","year":"2009","journal-title":"British Medical Journal"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0310","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1473-3099(04)01006-0","article-title":"Rationale for evaluating North America\u2019s first medically supervised safer-injecting facility","volume":"4","author":"Wood","year":"2004","journal-title":"The Lancet Infectious Diseases"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0315","first-page":"656","article-title":"Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users","volume":"169","author":"Wood","year":"2003","journal-title":"Canadian Medical Association Journal"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0320","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jpainsymman.2004.07.011","article-title":"Cannabis use in HIV for pain and other medical symptoms","volume":"29","author":"Woolridge","year":"2005","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0325","series-title":"Antiretroviral Treatment as Prevention (TasP) of HIV and TB","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.drugpo.2017.02.009_bib0330","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-015-1479-x","article-title":"Impact of unstable housing on all-cause mortality among persons who inject drugs","volume":"15","author":"Zivanovic","year":"2015","journal-title":"BMC Public Health"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917300579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917300579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T06:23:51Z","timestamp":1535955831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395917300579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":66,"alternative-id":["S0955395917300579"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.02.009","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-intensity cannabis use and HIV clinical outcomes among HIV-positive people who use illicit drugs in Vancouver, Canada","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}